Page last updated: 2024-08-21

cupric sulfide and Experimental Mammary Neoplasms

cupric sulfide has been researched along with Experimental Mammary Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Liao, G; Qin, Z; Qiu, M; Xiong, Z; Xu, Z; Yang, S; Zhang, Q1
Wu, A; Xing, J; Xu, X; Yang, F; Yao, C; Yao, J; Zheng, F1
Chen, AZ; Kankala, RK; Liu, CG; Liu, G; Tang, HX; Wang, SB; Yang, DY; Zhang, JT; Zhang, Y; Zheng, X1
Gao, Y; Li, D; Liu, R; Ouyang, Z; Shen, M; Shi, X; Song, C; Xiong, Z1
Cai, W; Chen, F; Ehlerding, EB; Goel, S; Graves, SA; Hong, H; Nickles, RJ; Orbay, H; Shi, S; Theuer, CP1
Chen, H; Chen, X; Cui, J; Guo, Z; Hu, G; Li, N; Song, M; Tang, J; Wang, L; Xu, S; Zhang, X1

Other Studies

6 other study(ies) available for cupric sulfide and Experimental Mammary Neoplasms

ArticleYear
Development of copper vacancy defects in a silver-doped CuS nanoplatform for high-efficiency photothermal-chemodynamic synergistic antitumor therapy.
    Journal of materials chemistry. B, 2021, 11-03, Volume: 9, Issue:42

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Copper; Drug Development; Female; Hemolysis; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Photothermal Therapy

2021
Boosting Chemodynamic Therapy
    ACS applied materials & interfaces, 2021, Nov-24, Volume: 13, Issue:46

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Copper; Drug Screening Assays, Antitumor; Female; Humans; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Manganese Compounds; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxides; Photosensitizing Agents; Photothermal Therapy; Tumor Cells, Cultured

2021
Near-Infrared-Activated Lysosome Pathway Death Induced by ROS Generated from Layered Double Hydroxide-Copper Sulfide Nanocomposites.
    ACS applied materials & interfaces, 2020, Sep-09, Volume: 12, Issue:36

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Membrane Permeability; Cells, Cultured; Copper; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Humans; Hydroxides; Infrared Rays; Lysosomes; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Nanocomposites; Particle Size; Photoacoustic Techniques; Photothermal Therapy; Reactive Oxygen Species; Surface Properties

2020
Antifouling Dendrimer-Entrapped Copper Sulfide Nanoparticles Enable Photoacoustic Imaging-Guided Targeted Combination Therapy of Tumors and Tumor Metastasis.
    ACS applied materials & interfaces, 2021, Feb-10, Volume: 13, Issue:5

    Topics: Animals; Antineoplastic Agents; Biofouling; Breast Neoplasms; Copper; Dendrimers; Female; Humans; Mammary Neoplasms, Experimental; Mice; Nanoparticles; Oligopeptides; Particle Size; Photoacoustic Techniques; Phototherapy; Polyethylene Glycols; Surface Properties; Tumor Cells, Cultured

2021
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
    ACS nano, 2015, Volume: 9, Issue:4

    Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution

2015
Ultrahigh (19)F Loaded Cu1.75S Nanoprobes for Simultaneous (19)F Magnetic Resonance Imaging and Photothermal Therapy.
    ACS nano, 2016, Jan-26, Volume: 10, Issue:1

    Topics: Animals; Cell Survival; Contrast Media; Copper; Female; Fluorine Radioisotopes; Fluorine-19 Magnetic Resonance Imaging; HeLa Cells; Humans; Injections, Subcutaneous; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Phototherapy

2016